Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
5.57
+0.19 (3.53%)
At close: Sep 21, 2026, 4:00 PM EDT
5.56
-0.01 (-0.18%)
After-hours: Sep 21, 2026, 7:54 PM EDT
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $121.9 million as of September 21, 2026. Its market cap has decreased by -48.41% in one year.
Market Cap
121.90M
Enterprise Value
48.71M
1-Year Change
-48.41%
Ranking
Category
Stock Price
$5.57
ChartMarket Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $121.90M, a decrease of -64.37%. That is a compound annual growth rate of -47.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 121.90M | -57.34% |
| Dec 31, 2025 | 285.77M | -16.48% |
| Feb 13, 2025 | 342.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProMIS Neurosciences | 125.64M |
| Cibus | 123.05M |
| Nautilus Biotechnology | 122.93M |
| Equillium | 121.74M |
| Rani Therapeutics Holdings | 120.16M |
| OnKure Therapeutics | 119.46M |
| Tiziana Life Sciences | 117.10M |
| Coya Therapeutics | 114.71M |